Relive SOLACI’s participation in the V International Congress of Clinical and Interventional Cardiology in the Dominican Republic

The Latin American Society of Interventional Cardiology actively participated in the “V International Congress of Clinical and Interventional Cardiology”, organized by the Asociación Dominicana de Cardiología Intervencionista in the Dominican Republic, an event held with the endorsement and institutional support of SOLACI.

The event took place on April 11, 2026, at the Convention Center of the Hodelpa Gran Almirante Hotel in Santiago, Dominican Republic.

SOLACI was represented by Dr. Marcelo Halac (ARG) and Dr. Omar Santaera (ARG), who participated as international faculty members, sharing their expertise and perspectives on the main challenges and advances in interventional cardiology in Latin America.

During his presentation, Dr. Marcelo Halac addressed the development and relevance of the Latin American registries promoted by SOLACI, highlighting their value as essential tools for generating regional evidence, understanding real-world clinical practice, and improving quality of care in interventional cardiology. He also presented the progress of multicenter registries on coronary bifurcation lesions and peripheral vascular disease, which currently include thousands of patients from multiple countries and centers across the region, consolidating themselves as strategic platforms for collaborative research and the development of guidelines adapted to the Latin American reality.

Meanwhile, Dr. Santaera delivered the lecture “Current Status of Percutaneous Coronary and Structural Intervention in Latin America”, in which he analyzed the regional scenario compared with Europe and the United States. During his presentation, he highlighted the existing gaps in access to coronary and structural procedures, such as angioplasty, TAVI, and left atrial appendage closure, as well as the need to strengthen continuous education, professional certification, referral centers, and regional registry systems in order to reduce cardiovascular mortality and expand access to high-complexity therapies throughout Latin America.

SOLACI’s participation in this important scientific meeting reaffirms the society’s commitment to continuing medical education, collaborative research, and the strengthening of interventional cardiology throughout the Latin American region.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Guatemala Sessions 2026 – Young Interventional Cardiologists Contest – Submit Your Case

The call for applications to participate in the Young Interventional Cardiologists Competition at the Guatemala 2026 Regional Sessions is now open. The event will...

Watch Again: Clinical Implications of Structural Heart Interventions — TAVI and MitraClip in Daily Practice

The recording of the webinar “Structural Interventions: TAVI and MitraClip in Daily Practice” is now available on the SOLACI YouTube channel. The activity was...

06/03 | SOLACI Technicians & Nurses Webinar – Clinical Impact of Structural Interventions: TAVI and MitraClip in Current Practice

The Latin American Society of Interventional Cardiology (SOLACI), through its Technicians and Nurses Department, invites you to participate in a new scientific webinar entitled...

Open Session | Current Endovascular Treatment of Tricuspid Regurgitation

SOLACI and the Argentine College of Interventional Cardioangiologists (CACI) invite you to participate in a new Open Session of the Advanced Postgraduate Course in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...